Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31361790 | 0.99 | ALOX5 (0.41) | ALOX5GAAKMT2AMEN1TDP1 | |
| SCHEMBL672759 | 0.99 | ALOX5 (0.41) | ALOX5GAAKMT2AMEN1TDP1 | |
| SCHEMBL10135978 | 0.97 | ALOX5 (0.44) | ALOX5GAAKMT2AMEN1TDP1 | |
| SCHEMBL906105 | 0.96 | ALDH1A1 (0.41) | ALOX5GAAKMT2AMEN1TDP1 | |
| SCHEMBL29768836 | 0.96 | ALDH1A1 (0.41) | ALOX5GAAKMT2AMEN1TDP1 | |
| SCHEMBL23533531 | 0.95 | CNR2 (0.41) | ALOX5GAAKMT2AMEN1MAOB | |
| SCHEMBL2491248 | 0.95 | CNR2 (0.41) | ALOX5GAAKMT2AMEN1MAOB | |
| SCHEMBL9871733 | 0.95 | CNR2 (0.41) | ALOX5GAAKMT2AMEN1MAOB | |
| SCHEMBL5630244 | 0.95 | CNR2 (0.41) | ALOX5GAAKMT2AMEN1MAOB | |
| SCHEMBL30996211 | 0.95 | ALDH1A1 (0.40) | ALOX5GAAKMT2AMEN1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034955-B2 | High molecular weight nonpolar benzotriazoles | BASF SE (DE) | 2015-05-19 | — | — | US | disclosed |
| US-9034955-B2 | High molecular weight nonpolar benzotriazoles | BASF SE (DE) | 2015-05-19 | — | — | US | disclosed |
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | SULT1A1, TPST2, SULT2A1 | ALOX5 1039/4885GAA 1298/4885KMT2A 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.